SCHEMBL21273095

SCHEMBL21273095

O=c1[nH]cnc2c1cc(Br)n2-c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
HPGD P15428 3/20 0.50
HSD17B10 Q99714 2/20 0.50
PDE4A P27815 2/20 0.45
PDE4B Q07343 2/20 0.45
PDE4C Q08493 2/20 0.45
PDE4D Q08499 2/20 0.45
SRC P12931 1/20 0.45
MAPK1 P28482 1/20 0.45
MAPT P10636 3/20 0.44
LMNA P02545 3/20 0.43
GAA P10253 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
PDPK1 O15530 1/20 0.42
CA12 O43570 1/20 0.42
PARP1 P09874 1/20 0.42
ALOX15 P16050 1/20 0.42
CA9 Q16790 1/20 0.42
TNKS2 Q9H2K2 1/20 0.42
CHEK1 O14757 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20971097 0.82 ALDH1A1 (0.50) ALDH1A1HPGDHSD17B10PDE4APDE4B
SCHEMBL21273061 0.82 ALDH1A1 (0.50) ALDH1A1HPGDHSD17B10PDE4APDE4B
SCHEMBL20971266 0.82 ALDH1A1 (0.50) ALDH1A1HPGDHSD17B10PDE4APDE4B
SCHEMBL20972969 0.79 ALDH1A1 (0.47) ALDH1A1HPGDHSD17B10PDE4APDE4B
SCHEMBL21272804 0.74 PIM1 (0.43) ALDH1A1HPGDHSD17B10PDE4APDE4B
SCHEMBL17869174 0.73 MAPT (0.55) ALDH1A1HPGDHSD17B10SRCMAPT
SCHEMBL20971053 0.71 SRC (0.55) ALDH1A1HPGDHSD17B10SRCMAPK1
SCHEMBL21273091 0.71 PARP1 (0.49) ALDH1A1HPGDHSD17B10MAPTCA12
SCHEMBL8801360 0.71 EGFR (0.57) ALDH1A1HPGDHSD17B10PDE4APDE4B
SCHEMBL21273016 0.70 MAPT (0.48) ALDH1A1HPGDHSD17B10PDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4026832-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 Almac Discovery Limited (GB) 2022-07-13 EP disclosed
US-10766903-B2 Piperidine derivatives as inhibitors of ubiquitin specific protease 7 ALMAC DISCOVERY LIMITED (GB) 2020-09-08 US disclosed
US-20190256518-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 GENETECH, INC. 2019-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190256518-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 USP7, USP5, UBA7 ALDH1A1 1201/4885HPGD 2893/4885HSD17B10 3230/4885
US-10766903-B2 Piperidine derivatives as inhibitors of ubiquitin specific protease 7 USP7, USP5, UBA7 ALDH1A1 1201/4885HPGD 2893/4885HSD17B10 3230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.